The $908 Billion Bipartisan Emergency COVID Relief Act of 2020 – While its outcome remains very much in doubt, the $908 Billion bipartisan compromise proposal put forward in the Senate includes a provision to temporarily extend the DEA waiver of the in-person requirement through the end of 2021.
We urge Congress to extend the Drug Enforcement Administration (DEA) waiver of the prior in-person requirement before telemedicine is allowed for prescribing of controlled substances under the Ryan Haight Act through the end of 2021. The DEA has waived this requirement for the duration of the COVID-19 Public Health Emergency (PHE). To provide stability and time for work on a more permanent policy, the waiver should be extended at least until the end of 2021. This provision is included in the $908 billion Bipartisan Emergency COVID Relief Act of 2020.
View the letter